Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Dwarfism, Pituitary 1Bone Diseases, Metabolic 1

Interventions

Everolimus 25Magnetic Resonance Spectroscopy 13pembrolizumab 12pasireotide 12Sunitinib 11Octreotide 11lanreotide 10cabozantinib 10lenvatinib 8Sorafenib 8Cisplatin 8Temozolomide 7Etoposide 7Bevacizumab 7pazopanib 6Paclitaxel 6Nivolumab 6Doxorubicin 6Carboplatin 6Capecitabine 6vandetanib 5gallium Ga 68 dotatate 5Specimen Handling 5trametinib 4lutetium Lu 177 dotatate 4dabrafenib 4Mitotane 4Iodine-131 4telotristat ethyl 3surufatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Risedronic Acid × Endocrine × Clear all
NCT00145704 2013-04-08

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

State University of New York - Upstate Medical University

Phase NA Terminated
6 enrolled 3 charts
Endocrine

Bone Diseases, Metabolic, Dwarfism, Pituitary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡